Page last updated: 2024-11-06

englitazone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

englitazone: structure given in first source; RN given refers to (+-)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID60303
CHEMBL ID55977
SCHEMBL ID37697
MeSH IDM0181307

Synonyms (5)

Synonym
englitazone
CHEMBL55977
SCHEMBL37697
DTXSID80883191
Q5378714

Research Excerpts

Actions

ExcerptReferenceRelevance
"Englitazone did not increase IR, IRS-1/IRS-2, pp60, or MAPK phosphorylation, nor did it enhance insulin's stimulation of these parameters."( Possibility of distinct insulin-signaling pathways beyond phosphatidylinositol 3-kinase-mediating glucose transport and lipogenesis.
Andrews, KM; Genereux, PE; Gibbs, EM; Kreutter, DK; Stevenson, RW, 1998
)
1.02
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID131961In vitro fold stimulation of glucose transporter protein in 3T3-L1 adipocytes at a concentration of 10 uM1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
AID169109In vitro stimulation of 2-Deoxyglucose uptake in L6 myocytes from rat skeletal myoblasts at a concentration of 30 uM1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
AID123048In vivo euglycemic activity (administered by oral gavage) in C57/6J-ob/ob mice by normalization of blood glucose levels at a dose of 10 mg/kg.1992Journal of medicinal chemistry, May-15, Volume: 35, Issue:10
Novel thiazolidine-2,4-diones as potent euglycemic agents.
AID131971In vivo percent glucose normalization in mice at a concentration of 25 mg/kg1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
AID131962In vitro fold stimulation of glucose transporter protein in 3T3-L1 adipocytes at a concentration of 30 uM1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
AID123169In vivo euglycemic activity of the compound (administered by oral gavage) in C57/6J-ob/ob mice is measured by normalization of blood glucose levels at a dose of 25(mg/kg)1992Journal of medicinal chemistry, May-15, Volume: 35, Issue:10
Novel thiazolidine-2,4-diones as potent euglycemic agents.
AID131970Compound was evaluated for in vivo for % glucose normalization in mice at a concentration of 2.5 mg/kg.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
AID131972Compound was evaluated for in vivo for % glucose normalization in mice at a concentration of 5 mg/kg.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
AID169108In vitro stimulation of 2-Deoxyglucose uptake in L6 myocytes from rat skeletal myoblasts at a concentration of 3 uM1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
AID131969Compound was evaluated for in vivo for % glucose normalization in mice at a concentration of 10 mg/kg.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
AID123170In vivo euglycemic activity (administered by oral gavage) in C57/6J-ob/ob mice measured by normalization of blood glucose levels at a dose of 5 mg/kg.1992Journal of medicinal chemistry, May-15, Volume: 35, Issue:10
Novel thiazolidine-2,4-diones as potent euglycemic agents.
AID169107In vitro stimulation of 2-Deoxyglucose uptake in L6 myocytes from rat skeletal myoblasts at a concentration of 10 uM1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's20 (80.00)18.2507
2000's5 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.21 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]